- Home
- AFCG vs PRE Comparison
AFCG vs PRE Comparison
Compare AFCG & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AFCG
- PRE
- Stock Information
- Founded
- AFCG 2020
- PRE 2014
- Country
- AFCG United States
- PRE Hong Kong
- Employees
- AFCG N/A
- PRE N/A
- Industry
- AFCG Real Estate Investment Trusts
- PRE Biotechnology: Laboratory Analytical Instruments
- Sector
- AFCG Real Estate
- PRE Industrials
- Exchange
- AFCG Nasdaq
- PRE Nasdaq
- Market Cap
- AFCG 127.4M
- PRE 105.1M
- IPO Year
- AFCG 2021
- PRE N/A
- Fundamental
- Price
- AFCG $4.41
- PRE $8.07
- Analyst Decision
- AFCG Buy
- PRE Buy
- Analyst Count
- AFCG 7
- PRE 1
- Target Price
- AFCG $11.00
- PRE $9.00
- AVG Volume (30 Days)
- AFCG 143.4K
- PRE 44.5K
- Earning Date
- AFCG 08-14-2025
- PRE 08-05-2025
- Dividend Yield
- AFCG 20.86%
- PRE N/A
- EPS Growth
- AFCG 84.02
- PRE N/A
- EPS
- AFCG 0.96
- PRE N/A
- Revenue
- AFCG $41,036,509.00
- PRE $41,520,000.00
- Revenue This Year
- AFCG N/A
- PRE $198.17
- Revenue Next Year
- AFCG $17.96
- PRE $59.73
- P/E Ratio
- AFCG $4.61
- PRE N/A
- Revenue Growth
- AFCG N/A
- PRE 78.72
- 52 Week Low
- AFCG $4.32
- PRE $3.10
- 52 Week High
- AFCG $10.88
- PRE $11.99
- Technical
- Relative Strength Index (RSI)
- AFCG 41.69
- PRE 49.95
- Support Level
- AFCG $4.50
- PRE $7.78
- Resistance Level
- AFCG $4.74
- PRE $8.31
- Average True Range (ATR)
- AFCG 0.16
- PRE 0.39
- MACD
- AFCG 0.00
- PRE -0.03
- Stochastic Oscillator
- AFCG 0.00
- PRE 37.18
About AFCG AFC Gamma Inc.
Advanced Flower Capital Inc is a commercial mortgage REIT that provides institutional loans to cannabis operators in the U.S. Through the management team's deep network and related credit and cannabis expertise. The company originates, structures, and underwrites loans secured by quality real estate assets, license value, and cash flows.
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.